Viewing Study NCT00547066


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-01-04 @ 1:16 PM
Study NCT ID: NCT00547066
Status: TERMINATED
Last Update Posted: 2021-08-16
First Post: 2007-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module